Form 6-K MorphoSys AG For: Aug 02

August 2, 2021 6:15 AM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

REPORT OF A FOREIGN ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For August 2, 2021

______________Commission File Number 1-38455______________

MorphoSys AG

Semmelweisstrasse 7

82152 Planegg

Germany

(Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ☐            No  ☒

If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

 



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    MORPHOSYS AG (Registrant)
Date: August 2, 2021     By:     /s/ i.A. Dr. Julia Neugebauer
      Name: Dr. Julia Neugebauer
      Title:   Senior Director Investor Relations
    By:   /s/ i.A. Dr. Robert Mayer     
      Name: Dr. Robert Mayer
      Title:   Director Investor Relations

Exhibit 99.1

Notification of managers`transactions according to article 19 MAR

Via Fax to BaFin (+49(0)228/4108-62963) and to the issuer

 

1

  Details of the person discharging managerial responsibilities/person closely associated
     

a)

  Name   

Krisja Vermeylen

   

2

  Reason for the notification
     

a)

  Position/status   

Member of the Supervisory Board of MorphoSys AG

     

b)

  Initial notification/Amendment   

Initial notification

   

3

  Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
     

a)

  Name   

MorphoSys AG

     

b)

  LEI   

529900493806K77LRE72

   

4

  Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
     

a)

 

Description of the financial instrument. type of instrument

Identification code

  

Shares of MorphoSys AG, ISIN DE0006632003

     

b)

  Nature of the transaction   

Acquisition

       

c)

  Price(s) and volume(s)    Price(s)     Volume(s) 
    

47.2533  

   16,538.66  
      
     

d)

 

Aggregated information

 

-  Aggregated volume

 

-  Price

  

 

 

16,538.66

 

47.2533

 

     

e)

 

Date of the transaction

  

2021-07-29; UTC+1

     

f)

 

Place of the transaction

  

Xetra

 

 

(1)  Commission Delegated Regulation (EU) 2016/522 of 17 December 2015 supplementing Regulation (EU) No 596/2014 of the European Parliament and of the Council as regards an exemption for certain third countries public bodies and central banks. the indicators of market manipulation. the disclosure thresholds. the competent authority for notifications of delays. the permission for trading during closed periods and types of notifiable managers’ transactions (see page 1 of this Official Journal).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings